Sign In
Buy MNOV
$1.36
+0.0600 (+4.62%)
At Close: Jun 23, 2026
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:
LA JOLLA, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange�
MNOV: Developing SARS-CoV-2 Vaccine Based on Parainfluenza Virus Vector…
11:40am, Tuesday, 04'th Aug 2020
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update Licenses SARS-CoV-2 Vaccine On July 27, 2020, MediciNova, Inc. (NASDAQ:MNOV) announced the company entered into a joi
MediciNova to Participate in the Morgan Stanley Virtual 18th Annual Global Healthcare Conference
10:30am, Tuesday, 04'th Aug 2020
LA JOLLA, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Co
MediciNova (NASDAQ:MNOV) Earns “Buy” Rating from B. Riley
03:14am, Tuesday, 04'th Aug 2020
MediciNova (NASDAQ:MNOV)‘s stock had its “buy” rating reiterated by equities researchers at B. Riley in a research report issued to clients and investors on Monday, TipRanks reports. They curren
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) * Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) * Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO) * Fulgent Genetics
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 27)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
Here's Why MediciNova Is Soaring Today
05:09pm, Monday, 27'th Jul 2020
Shares of MediciNova (NASDAQ: MNOV) jumped over 65% today after the company announced a collaboration with BioComo and Mie University to develop a vaccine against SARS-CoV-2. The technology platform
MediciNova Announces SARS-CoV-2 Vaccine Joint Development with BioComo and Mie University Japan
10:30am, Monday, 27'th Jul 2020
LA JOLLA, Calif., July 27, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Co
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.43%
12:00am, Monday, 27'th Jul 2020
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.43%
MediciNova to Participate in Panel Discussion at the B. Riley FBR Virtual Infectious Disease Summit
10:30am, Monday, 20'th Jul 2020
LA JOLLA, Calif., July 20, 2020 -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock.
Acute Respiratory Distress Syndrome (ARDS) - Market Insights, Epidemiology and Forecast to 2030 - ResearchAndMarkets.com
12:00am, Tuesday, 14'th Jul 2020
The
MNOV: FDA Gives OK to Initiate Clinical Trial of MN-166 to Prevent ARDS in COVID-19 Patients…
09:47am, Thursday, 02'nd Jul 2020
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update FDA Approves Clinical Plan for MN-166 to Prevent ARDS Caused by COVID-19 On July 1, 2020, MediciNova, Inc. (NASDAQ:MN
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the Investigational
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
12:28pm, Friday, 26'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25) * Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) *
